Nuclera’s mission is to accelerate discovery by providing researchers rapid, easy access to the highest-quality functional proteins essential for drug discovery research. The Company’s eProtein Discovery™ benchtop system combines unique cell-free expression systems, novel digital microfluidics, and robust screening data to empower scientists to perform multiplex protein screening, characterization, and small-scale expression in-house.[BR1]
By providing clear guidance on which protein has the best chance of success from the start, eProtein Discovery™ reduces the time, cost, and uncertainty traditionally associated with protein expression and purification. Researchers can generate soluble, purified proteins, including challenging membrane proteins[BR2] , for downstream functional testing in under 48 hours, significantly accelerating workflows compared with months-long cell-based methods.
Founded in 2013, Nuclera has offices in Cambridge (UK) and Boston (US).
For more information, please visit www.nuclera.com